What is the relationship between Huaxi Bio and Freda?

From the perspective of heaven, the two companies have no holding relationship. However, there have been some related transactions between Huaxi Bio and Freda.

Freda's predecessor was Huaxi Biotechnology, and Shandong Freda was renamed Huaxi Freda on 20 12. In addition, Freda is a shareholder in the early days of Huaxi Biotechnology. Later, after many changes, Freda transferred 5.63% equity of Shandong Huaxi Freda Biomedical Co., Ltd. to Huaxi Company, realizing the equity divestiture. Their relationship can really be composed of you and me. It is very difficult to separate the past development history of West China creatures from Freda. Freda's technology, management level and some equity have played a particularly important role. Freda bought a technology from Shandong Biopharmaceutical Research Institute from the beginning, and it was bought in the form of monopoly. Therefore, in the current business, Freda and its related enterprises are also suppliers and customers of Huaxi Bio.

Huaxi Biological Company is a well-known biotechnology company and bioactive materials company, which mainly focuses on functional sugars and amino acids that are beneficial to human health and is committed to bringing healthy, beautiful and happy new life experiences to mankind.

The company is a hyaluronic acid industrial chain platform company integrating R&D, production and sales, and the technology of producing hyaluronic acid by microbial fermentation is in an advantageous position. Relying on the bio-fermentation technology platform and industrialization advantages, the company has developed a series of bioactive products with hyaluronic acid as the core. Among them, hyaluronic acid includes nearly 200 specifications of medicines, cosmetics and foods, which are widely used in the fields of medicines, medical devices, cosmetics and functional foods. Other bioactive products include lidocaine, ergothionine, γ -aminobutyric acid, polyglutamic acid, sclerotium gel, natto extract, brown rice fermentation filtrate, etc.

Shandong Freda Pharmaceutical Group Co., Ltd. was established in June1April 993 17, formerly known as Shandong Biochemical Pharmaceutical Company, and is affiliated to Shandong Commercial Group Co., Ltd., which is a modern large-scale high-tech industrial group integrating science, industry and trade. The industry involves drugs, health food, cosmetics, medical devices and raw materials. It owns many well-known brands such as Runshu, Runjie, Spat, Akihito and Yilian. 20 1 1 year, the sales revenue of Freda Pharmaceutical Group is 1.73 billion yuan, and the profit and tax is 368 million yuan. Shandong Doctor Lun Freda Pharmaceutical Co., Ltd. has developed into the largest production base of ophthalmic drugs in China, and its products have occupied 20% of the domestic market share of ophthalmic drugs. Shandong Freda Biomedical Co., Ltd. relies on the technical advantages of producing hyaluronic acid by fermentation, and its products not only occupy the main market share in the domestic market, but also are exported to Japan, the United States, Europe, South Korea and other international markets.